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Abstract. Small GTPases of the rab family are involved 
in the regulation of vesicular transport. It is believed 
that cycling between the GTP- and GDP-bound forms, 
and accessory factors regulating this cycling are crucial 
for rab function. However, an essential role for rab nu- 
cleotide exchange factors has not yet been demon- 
strated. In this report we show the requirement of nu- 
cleotide exchange factor activity for Yptl GTPase 
mediated protein transport. The Yptl protein, a mem- 
ber of the rab family, plays a role in targeting vesicles to 
the acceptor compartment and is essential for the first 
two steps of the yeast secretory pathway. We use two 
YPTI dominant mutations that contain alterations in a 
highly conserved GTP-binding domain, N121I and 
D124N. YPT1-D124N is a novel mutation that encodes 
a protein with nucleotide specificity modified from gua- 
nine to xanthine. This provides a tool for the study of 
an individual rab GTPase in crude extracts: a xan- 
thosine triphosphate (XTP)-dependent conditional 
dominant mutation. Both mutations confer growth in- 
hibition and a block in protein secretion when ex- 
pressed in vivo. The purified mutant proteins do not 
bind either GDP or GTP. Moreover, they completely 
inhibit the ability of the exchange factor to stimulate 
nucleotide exchange for wild type Yptl protein, and are 
potent inhibitors of ER to Golgi transport in vitro at 
the vesicle targeting step. The inhibitory effects of the 
Yptl-D124N mutant protein on both nucleotide ex- 
change activity and protein transport in vitro can be re- 
lieved by XTP, indicating that it is the nucleotide-free 
form of the mutant protein that is inhibitory. These re- 
sults suggest that the dominant mutant proteins inhibit 
protein transport by sequestering the exchange factor 
from the wild type Yptl protein, and that this factor has 
an essential role in vesicular transport. 
T 
HE passage of proteins through the secretory path- 
way involves their orderly progression through a se- 
ries of membranous compartments (Palade,  1975). 
Transport between successive secretory compartments ap- 
pears to be mediated by vesicles (Jamieson  and Palade, 
1967; Pfeffer and Rothman, 1987; Rothman, 1994).  How- 
ever, the mechanisms that regulate the directionality and 
specificity of these vesicular transport steps are not known. 
The  rab/Yptl/Sec4  family  of  small  GTPases  has  been 
shown to play a role in vesicular trafficking (Ferro-Novick 
and Novick, 1993; Zerial and Stenmark, 1993). It has been 
suggested that these proteins act at the different steps of 
the secretory pathway to ensure the fidelity of vesicular 
targeting  (Bourne,  1988;  Segev et  al.,  1988;  Lian et  al., 
1994; SCgarrd et al., 1994). The ability of rab proteins to 
cycle between GTP- and GDP-bound forms is believed to 
be crucial for their function (Bourne, et al.,  1990). The 
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shift from the  GTP- to the  GDP-bound form is  accom- 
plished by the endogenous GTPase activity of these pro- 
teins, while the change from the GDP- to the GTP-bound 
form is achieved by nucleotide exchange. Most GTP-bind- 
ing proteins have slow intrinsic rates of guanine nucleotide 
exchange, and thus require accessory factors to stimulate 
the exchange reaction. 
The importance of nucleotide exchange for function of 
rab-GTPases has been implied in several studies. First, rab 
proteins  that  have  a  mutation  analogous  to  ras-S17N, 
which locks the  GTPase in  the  GDP-bound form, have 
been shown to inhibit protein transport in vivo and in vitro 
(Tisdale  et al.,  1992;  Li and  Stahl,  1993;  Nuoffer et al., 
1994; Riederer et al., 1994; Stenmark et al., 1994). Second, 
the bulk of the cytosolic pool of several rab proteins is ap- 
parently in  the  GDP-bound state,  since it is  found in  a 
complex with GDP-dissociation inhibitory factor (GDI)  1 
1. Abbreviations used in this paper: CPY, carboxypeptidase Y; EF, elonga- 
tion factor; 5-FOA, 5-fluoro-orotic acid; GAP, GTPase-activating protein; 
GDS,  GDP dissociation stimulators; GDI,  GDP-dissociation inhibitory 
factor; S-raffinose, synthetic-raffinose; Yptlp, Yptl  protein; XTP,  xan- 
thosine triphosphate. 
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1993),  which  has been shown  to  associate only with  the 
GDP-bound  form  of  rab  proteins  (Araki  et  al.,  1990). 
Third, a temporal correlation has been found between the 
association of rab5 and rab9 with membranous compart- 
ments and binding of GTP to these proteins (Soldati et al., 
1994; Ullrich et al., 1994). Thus, it has been suggested that 
guanine  nucleotide  exchange  is  crucial  for  rab  protein 
function, and may play a role in recruitment of the protein 
to its target membrane. 
Factors  that  stimulate  nucleotide  exchange  have been 
identified  for members of the  ras and  rho families (Bo- 
guski and McCormick, 1993) and also for elongation factor 
(EF)  Tu  (Kaziro,  1978).  Less is known  about  exchange 
factors for rab-GTPases. To date, three GDP dissociation 
stimulators (GDS) for rab proteins have been described. 
The  yeast  DSS4  and  the  mammalian ross4  genes  were 
identified  based  on  their  ability  to  suppress  a  recessive 
sec4 mutation in yeast (Moya et al.,  1993;  Burton  et al., 
1993,  respectively). The third  factor, Rab3A-GRF  (gua- 
nine-nucleotide  release  factor),  is  a  mammalian protein 
that was identified as a biochemical activity which stimu- 
lates GDP release from the Rab3A protein (Burstein and 
Macara,  1992).  Even  though  their  specificity appears to 
overlap, Rab3A-GRF and Mss4 were suggested to be two 
distinct factors based on the fact that unlike Mss4, Rab3A- 
GRF  is  more  effective  on  the  lipid-modified  form  of 
Rab3A  than  on  its  unmodified  form  (Miyazaki  et  al., 
1994).  Deletion  of DSS4  is not  lethal  to yeast cells  and 
does not seem to affect cell growth or secretion,  despite 
the fact that SEC4 function is essential for viability and se- 
cretion  (Moya  et  al.,  1993).  This  observation  raises  the 
questions  of whether  Dss4p  is the  only exchange factor 
acting on Sec4p and, more importantly, whether guanine 
nucleotide exchange factors are essential for rab function. 
We have identified  an exchange factor for Yptl  protein 
(Yptlp) in yeast. This factor is distinct from Dss4p,  and 
stimulates both GDP release and GTP uptake by Yptlp 
(Jones, S., R. J. Litt, and N. Segev, manuscript in prepara- 
tion). In the present paper, we explore the role of this nu- 
cleotide  exchange  factor  by  taking  advantage  of  Yptl 
dominant mutant proteins that inhibit its activity. 
We used two dominant interfering mutations of YPT1 
that change residues in a guanine-binding domain that is 
highly  conserved  in  all  GTPases.  The  first  mutation  is 
YPT1-N121I (Schmitt et al., 1986). A corresponding muta- 
tion has been studied in several rab proteins in yeast and 
mammalian cells. Mutant rab proteins carrying this muta- 
tion have been shown to interfere with protein transport in 
vivo and in vitro and to have a reduced affinity for guanine 
nucleotides  (Wagner  et al.,  1987;  Walworth  et al.,  1989; 
Gorvel et al., 1991;  Bucci et al., 1992; Tisdale et al., 1992; 
Brondyk et al., 1993).  The mechanism by which this muta- 
tion exerts its dominant effect in rab proteins has yet to be 
established. The second mutation, YPT1-D124N, is analo- 
gous  to  the  EF-Tu  mutation  D138N,  which  has  been 
shown  to confer  a  defect in  nucleotide  binding  (Hwang 
and Miller,  1987).  Two other EF-Tu mutants with  alter- 
ations in the same consensus domain, K136E/Q,  are also 
defective in  nucleotide  binding.  These  two  mutant  pro- 
teins exert their dominant negative effects by sequestering 
EF-Ts, the exchange factor for EF-Tu (Hwang et al., 1989). 
A  similar mechanism of action has been demonstrated for 
ms  dominant  interfering  mutations  in  this  and  another 
GTP-binding consensus domain (Powers et al., 1989, 1991; 
Hwang et al.,  1993;  Lai et  al.,  1993;  Haney and  Broach, 
1994). 
In this study, we used dominant interfering mutants of 
the Yptl-GTPase to assess the role of its exchange factor 
in protein transport.  Yptl  protein,  a  member of the  rab 
family, is essential for the first two steps of the yeast secre- 
tory pathway, ER to Golgi, and cis- to medial-Golgi appa- 
ratus, mediating  the targeting  and/or  fusion  of transport 
vesicles (Segev et al., 1988; Bacon et al., 1989; Rexach and 
Schekman, 1991;  Segev, 1991; Jedd, G., C. J. Richardson, 
R. J. Litt, and N. Segev, manuscript in preparation). The 
two  dominant  mutant  Yptl  proteins,  Yptl-N121I  and 
Yptl-D124N, fail to bind guanine nueleotides, and they in- 
hibit protein transport in vivo and in vitro. They do so by 
blocking the activity of the exchange factor for Yptlp, thus 
demonstrating the importance of this factor in secretion. 
YPT1-D124N is a novel mutation, which by analogy to a 
similar mutation in EF-Tu is predicted to change the spec- 
ificity of nucleotide binding from guanosine phosphates to 
xanthosine  phosphates  (Hwang  and  Miller,  1987).  The 
D124N mutation has the same effect on nucleotide speci- 
ficity in the Yptlp.  As a  consequence,  the  inhibitory ef- 
fects of the Yptl  mutant protein in the  exchange and in 
vitro transport assays can be alleviated by providing XTP. 
It is likely that the D124N mutation will have a similar ef- 
fect on other rab proteins, thus providing a new tool for 
the study of specific rab proteins in crude extracts. In addi- 
tion, since the mutant proteins seem to exert their domi- 
nance by sequestering the exchange factor, they are poten- 
tial tools for the isolation of these factors. 
Materials and Methods 
Strains, Plasmids, and Materials 
The following yeast strains were used in this study: GPY60 (MATa ura3- 
52  trpl  leu2 his4 pep4::URA3),  NSY181  (MATa/a his3-~12OO/his3-zl200 
leu2-3  j12/leu2-3,112 lys2-801/lys2-80l ura3-52/ura3-52),  NSY125 (DBY1034; 
MATa his4-539  lys2-801  ura3-52).  Yeast  and bacterial  transformations 
were  performed  by  electroporation  (Dower  et  al.,  1988;  Becker  and 
Guarente, 1991). 
Plasmids were constructed for the inducible expression of wild type and 
mutant YPT1 alleles in yeast. They contain the EcoRV to BamHI frag- 
ment  containing  the  entire  YPTI  open  reading  frame  inserted  into 
pRS316 (CEN-URA3)  (Sikorski and Hieter, 1989)  and the GALIO pro- 
moter (Johnston and Davis, 1984). Mutant YPT1 alleles were constructed 
by site directed mutagenesis as described below. Yeast expression plas- 
raids were designated pRS326, wild type YPTI; pRS327, YPT1-N1211 and 
pRS317,  YPT1-D124N.  Yeast  strains  carrying  these  plasmids express 
Yptlp when grown on medium containing galactose. 
Plasmids for the expression of GST fusion proteins in Escherichia coli 
were  constructed in  pGEX-KT  (Hakes  and  Dixon,  1992)  by  inserting 
BamHI fragments containing the entire YPT1 open reading frame from 
pRS351  (wild  type  YPT1),  pRS360  (YPT1-N1211),  or pRS318  (YPTI- 
D124N)  (see below) into the BamHI site of the vector. Bacterial plasmids 
for  the  expression  of  the  GST-Yptl  fusion proteins  were  designated 
pRS361, wild type YptIp;  pRS362, Yptlp-D124N,  and pRS363 Yptlp- 
N121I. Thrombin cleavage of the fusion proteins yields Yptl protein with 
a two amino acid extension (Gly-Ser) appended to the amino terminus. 
All chemical reagents were purchased from Sigma Chemical Co. (St. 
Louis, MO), unless otherwise noted. 
Culture Conditions 
Yeast strains were grown in rich medium (YEP, 1% yeast extract, 2% bac- 
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amino acids)  supplemented with  the  appropriate  auxotrophic  require- 
ments (Rose et al., 1988).  Unless otherwise noted, carbon sources were 
added to 2% (wt/vol). 
Site-directed Mutagenesis 
YPTI mutations were made in the E. coli phagemid vector pIBI31 (Inter- 
national Biotechnologies, Inc., New Haven, CT) containing the EcoRI to 
BamHI fragment of YPT1. Mutants were constructed by the method of 
Kunkel (1987) and tested in strain NSY125. Constructs were designated 
pRS300,  wild-type  YPT1;  pRS301,  YPT1-N121I  and  pRS318  YPT1- 
D124N. Mutagenic oligonucleotides were: YPT1-N1211: AAG CTA TTG 
GTA GGT ATC AAG TGT GAT TTA AAG; or YPT1-D124N: GTA 
GGT AAC AAG TGT AAT TTA AAG GAC AAG CGT. Mutant alle- 
les were confirmed by sequence analysis using Sequenase (United States 
Biochemical, Cleveland, OH). 
Random Mutagenesis 
Plasmid pRS326 (wild type YPT1) was mutagenized in vitro with hydroxy- 
lamine as described (Rose et al., 1988). The frequency of mutagenesis was 
2% as determined by the loss of URA3 function in bacteria. Mutagenized 
plasmids were introduced into the YPT1 wild type strain NSY181. Ura ÷ 
yeast transformants were selected and screened for their inability to grow 
in the presence of galactose. Strains that were unable to grow on galactose 
were  considered potential  dominant mutants. Those that  regained  the 
ability to grow on galactose following 5-fluoro-orotic acid (5-FOA) selec- 
tion (Boeke et al., 1987) were retained. Plasmids containing candidate mu- 
tations were  isolated  as  described  (Hoffman and  Winston,  1987).  The 
identity of the YPT1 mutation was determined by sequence analysis. A 
screen of 12,000 yeast transformants yielded two dominant lethal alleles of 
YPT1.  Both of these alleles were  novel. The screen was not saturating 
since it failed to yield a previously identified dominant interfering muta- 
tion (Schmitt et al., 1986). 
In Vivo Protein Labeling and 
CPY Immunoprecipitation 
Derivatives of strain NSY125 transformed with pRS326-based yeast ex- 
pression vectors were grown to 0.2 A600  U/ml, in synthetic-raffinose (S-raffi- 
nose) -URA dropout medium. D-galactose was added to a final concen- 
tration of 2%  (wt/vol)  and cells were incubated at 30°C for 3 h  before 
labeling. Cells were pelleted and resuspended to 5 Ar00 U/ml in S-raffi- 
nose-URA medium with 150 ~Ci/ml Tran35S-label (~1,000 Ci/mmol; ICN 
Biochemicals, Inc.,  Irvine,  CA).  Metabolic  labeling was carried  out at 
30°C for 10 min. Cells were pelleted and chase was initiated by resuspen- 
sion in  S-raffinose-URA medium with  0.003%  L-cysteine and  0.004% 
L-methionine (wt/vol).  Samples of 0.2  ml  were  taken  at  intervals  and 
placed on ice; sodium azide was added to 10 mM. Cells were pelleted and 
resuspended in 0.1 ml of lysis buffer (50 mM Tris, pH 7.5, 6 M  urea, 1% 
SDS, 1 mM EDTA). An equal volume of glass beads was added and sam- 
ples were vortexed for 1 min and boiled for 5 min. 0.9 ml dilution buffer 
(50 mM Tris, pH 7.5,  1.25% Triton X-100, 190 mM NaC1, 6 mM EDTA) 
was added and samples were centrifuged at 16,000 g for 10 min at 4°C. Ly- 
sates were pre-cleared with 20 I~l of a 50% slurry of protein A-Sepharose 
pre-hound to rabbit anti-mouse IgG (Zymed Labs, San Francisco, CA). 
CPY  was  immunoprecipitated with  mouse anti-CPY monoclonal anti- 
body  and  immunocomplexes were  washed  as  described  (Graham  and 
Emr, 1991),  electrophoresed on 12% SDS-PAGE (Laemmli, 1970),  pro- 
cessed for fluorography, and visualized by autoradiography. 
Purification of  Mutant Ypt  l Proteins 
GST fusion proteins were purified as described (Smith and Johnson, 1988) 
except that induction was carried out at 25°C, 10 mM MgCI2 was included 
in all steps and binding to glutathione agarose was carried out at 4°C for 1 h. 
Following  thrombin  cleavage,  Yptlp-containing  fractions  were  pooled 
and dialyzed against buffer 88 (250 mM sorbitol, 20 mM Hepes, pH 6.8, 
150 mM KOAc, 5 mM Mg[OAc]2) (Baker et al., 1988). 
Guanine Nucleotide Binding Assays 
Yptl protein (50 ~g/ml) in buffer 88 was incubated at 30°C with 3.2 mM 
3H-5',8'-GDP (New England Nuclear, Boston, MA) or 32p-et-GTP  (Am- 
ersham Corp., Arlington Heights, IL) diluted to a specific activity of ap- 
proximately 15 Ci/mmol and EDTA to bring the free concentration of 
Mg  + to ~0.1 I~M (Sunyer et al., 1984).  Samples containing 0.1  I~g Yptlp 
were removed at intervals and were applied to wet nitrocellulose filters 
(BA85; Schliecher & Schuell, Keene, NH) which were then washed twice 
with 3 ml of ice cold wash buffer (20 mM Tris-HC1, pH 7.5, 20 mM NaC1, 5 
mM MgCI  2, 1 mM DTT). Background was assessed by a parallel sample 
that contained BSA in place of Yptlp. Radioactivity bound to the filters 
was quantified by liquid scintillation spectrometry using Ready Protein+ 
(Beckman Instruments, Palo Alto, CA) or Filtron-X (National Diagnos- 
tics, Atlanta, GA) scintillation fluid. Mutant proteins never bound nucle- 
otides above background, and the given estimates express the lowest de- 
tection limit of the assay. 
GDP Release Assays 
20 pmol Yptlp were preloaded by incubating with 40 pmol 5',8'-3H-GDP 
(S.A.  31.7  Ci/mmol; New  England Nuclear)  in preload  buffer (20 mM 
Hepes, pH 7.2, 20 mM KOAc, 1 mM Dq'T, 5 mM EDTA) for 10 min at 
30°C. At the end of the incubation, samples were moved to ice and MgCl2 
was added to 5 mM. 3H-GDP remained stably bound to the Yptlp treated 
in this way for at least 1 h. The P100 cell fraction (Baker et al., 1990) which 
contains the stimulating exchange activity for Yptlp or BSA (unstimu- 
lated control) were diluted into reaction buffer (20 mM Hepes, pH 7.2, 5 
mM Mg[OAc]2, 0.75 mM GTP, 0.75 mM GDP, 1 mM DTT) and exchange 
reactions were initiated by the addition of 10 pmol Yptlp-aH-GDP. The 
reaction volume was 50 ~l. Incubations were carried out at 30°C for vary- 
ing periods of time, as noted. To monitor the release of 3H-GDP from 
Yptlp, 5 ~l samples were filtered, washed and counted as above. In all ex- 
periments, initial  values were  approximately 8-10  ×  103 dpm per  5-~1 
sample (Jones, S., R. J. Litt, and N. Segev, manuscript in preparation). 
GTP Uptake Assays 
Bacterially expressed Yptlp was preloaded as described for the GDP re- 
lease assay, but with non-radioactive GDP. As a source of exchange activ- 
ity we used a cellular fraction from which the endogenous Yptlp was ex- 
tracted. The P100 fraction was treated with 1% Triton X-100 for 1 h  on 
ice. Following centrifugation at 100,000  g  for 1 h, the pellet, which con- 
tained ~90% of the exchange activity, was resuspended in buffer 88 and 
further extracted with 0.5 M NaC1 for 1 h on ice. A final centrifugation at 
100,000 g for 1 h yielded a supernatant (termed TNS100) which contained 
~75% of the total exchange activity in the original P100 fraction (Jones, 
S.,  R. J. Litt, and N. Segev, manuscript in preparation).  The preloaded 
Yptlp  and TNS100 fraction or  ovalbumin (unstimulated control)  were 
added to reaction buffer lacking GTP or GDP. ATP was added to 1 mM 
to prevent hydrolysis of 32p-GTP. t~JZP-GTP (Amersham Corp.; 3,000 Ci/ 
mmol) was diluted to a specific activity of 75 Ci/mmol. Exchange reactions 
were initiated by the addition of 100 pmol GTP to a 50 Ixl reaction mixture 
containing 10 pmol Yptlp and 20 p.g TNS100. Samples of 5 txl were re- 
moved at intervals and the amount of a-32p-GTP bound to Yptlp was de- 
termined by quantitative immunoprecipitation with anti-Yptlp antibod- 
ies. Immunoprecipitation was necessary to distinguish between Yptlp and 
other GTP-binding proteins present in the TNS100 extract (Jones, S., R. J. 
Litt, and N. Segev, manuscript in preparation). 
ER to Golgi Transport Assay 
In vitro ER to Golgi transport assays were carried out as described (Baker 
et al., 1988,  1990).  Membranes (Baker et al., 1990)  and cytosol (Wueste- 
hube and Schekman, 1992) were prepared as described. 
Results 
Isolation and In Vivo Characterization of  a New 
Dominant Lethal Allele of YPT1 
We  wished  to  identify  new  dominant  YPT1  mutations 
which, by analogy to EF-Tu and RAS2 (see above), might 
prove to be valuable for analysis of the exchange factor 
that acts on Yptlp. Since we expected that such mutations 
would be lethal, the Saccharomyces cerevisiae YPT1 gene 
Jones et al. Requirement of Exchange Factor  for Ypt  l  GTPase  1053 was  placed  under  control  of the  inducible  GALIO pro- 
moter.  We identified  several new dominant lethal  alleles 
of YPT1 by random or site-directed mutageneses.  One of 
the mutations identified  by both methods resulted  in the 
substitution of an asparagine residue in place of an aspar- 
tare  at  position  124  of  Yptlp.  This  allele,  designated 
YPT1-D124N, is a new allele of YPT1 that is similar to ex- 
isting mutations  in EF-Tu (Hwang and Miller,  1987)  and 
the human (Feig et al., 1986; McCormick et al., 1987) and 
Caenorhabditis  elegans  (Han  and  Sternberg,  1991)  ras 
genes.  A  dominant  mutation  in  a  neighboring  residue, 
YPT1-N121L  was  originally  isolated  by  Schmitt  et  al. 
(1986) and is similar to existing mutations in ras (Clanton 
et  al.,  1986; Der  et  al.,  1986; Walter,  et  al.,  1986)  and in 
other rab proteins  (Walworth  et  al.,  1989;  Gorvel  et  al., 
1991; Tisdale et al., 1992; Brondyk et al., 1993). Expression 
of  either  YPT1-D124N  or  YPT1-N121I  in  yeast  cells 
caused growth arrest  (Fig.  1 a; and Schmitt  et  al.,  1986). 
Both mutant phenotypes exhibited some temperature  de- 
pendence, with the lethal effects being more pronounced 
at low temperatures  (data not shown). Unlike the behav- 
ior  of the  SEC4-N133I mutation,  which  is  analogous  to 
YPT1-N121I (Walworth  et  al.,  1989),  attempts  to  trans- 
form cells with  CEN plasmids  carrying either  YPT1 mu- 
tant allele under the control of its own promoter were un- 
successful.  These  results  suggest  that  even  low  levels  of 
expression are sufficient to confer the dominant lethal ef- 
fect. Replacement of two terminal cysteine residues, which 
are necessary for prenylation, with serine residues did not 
alleviate  the  lethal  phenotype  of YPT1-N1211 when  the 
doubly mutant  allele  was expressed  under control of the 
GALIO promoter  (data  not shown).  Thus,  the  dominant 
effect of YPT1-N121I in vivo is apparently not dependent 
upon  prenylation.  This  feature  of the  dominant  mutant 
protein  encouraged us  to use  a  bacterially  produced  un- 
prenylated protein for further biochemical analysis. 
Loss of Yptlp activity results in a defect in the first two 
steps  of the yeast secretory pathway  (Segev et  al.,  1988; 
Bacon et  al.,  1989; Jedd,  G.,  R.  J.  Litt,  C. J.  Richardson, 
and N. Segev, manuscript in preparation).  Yeast cells ex- 
pressing the Yptl-N121I or -D124N dominant mutant pro- 
teins  exhibit  similar  defects  in  protein  transport  in  vivo. 
The effect of expressing the mutant proteins  on vesicular 
transport  was assayed by following the  processing of the 
vacuolar  protein  carboxypeptidase  Y  (CPY).  As  CPY 
traverses  the secretory pathway it progresses from a  core 
glycosylated,  ER  form  (pl),  to  an  outer-chain  glycosy- 
lated, Golgi form (p2), and finally to a proteolytically pro- 
cessed,  mature  vacuolar  form  (m).  Pulse-chase  experi- 
ments,  followed  by  immunoprecipitation  of  CPY,  were 
performed  using strains  carrying galactose-inducible  wild 
type  YPT1,  YPT1-N1211, or YPT1-D124N alleles  (Fig.  1 
b).  Cells  expressing  the  wild  type  Yptl  protein,  or cells 
carrying the YPT1-N121I or -D124N allele but grown un- 
der  non-inducing  conditions  (glucose),  process  ~90%  of 
the CPY to the mature form within 10 min of chase (Fig. 1 
b,  and  data  not  shown).  Expression  of either  dominant 
mutant allele significantly slows transport of CPY through 
the secretory pathway, with the pl form and a broad band 
above it persisting even after an hour of chase (Fig. 1 b). A 
more  detailed  characterization  of  the  effect  of  YPT1- 
N121I on CPY transport showed that the immature  CPY 
forms that  accumulate in these  cells  are  the  ER and cis- 
Golgi forms (Jedd, G., C. J. Richardson, R. J. Litt, and N. 
Segev, manuscript  in preparation).  In the  time  course  of 
the secretion experiment (4 h) there was no effect on cell 
Figure 1.  The dominant YPT1 mutations N1211 and D124N cause growth inhibition and a protein secretion defect in vivo. (a) Expres- 
sion of these dominant negative mutants inhibits  cell growth. Yeast cells (NSY125) transformed with empty vector or plasmids carrying 
galactose-inducible wild type or mutant YPT1 alleles were streaked on synthetic raffinose medium (S-raffinose-URA) without (left) or 
with (right) 2% galactose. (b) Expression of dominant negative mutants perturbs the secretory pathway. Yeast cells (NSY125)  trans- 
formed with plasmids carrying wild type or mutant YPT1 aIleles were grown to early log phase in S-raffinose-URA. Wild type or mutant 
Yptl protein were induced by the addition of 2% galactose for 3 h. The ceils were pulse labeled with 35S-translabel for 10 rain at 30°C, 
and then chased with excess cold methionine and cysteine. Samples were removed at indicated chase time points and CPY was immuno- 
precipitated from whole cell lysates.  Samples were analyzed by SDS-PAGE and fluorography. The secretory phenotype is apparent al- 
ready after the pulse, chase time 0, because the mutant alleles were induced for 3 h prior to labeling. 
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pidium iodide (Corliss and White, 1981) (data not shown). 
The growth  and  secretion phenotypes conferred by the 
YPT1-N121I allele were more severe than those caused by 
YPT1-D124N. Western blot analysis showed that levels of 
Yptl protein expression were similar in strains expressing 
either allele (data not shown). Since the two proteins are 
equally potent inhibitors in vitro (see below), we suggest 
that the observed difference in vivo was due to the pres- 
ence  of xanthine  nucleotides  in  the  cell  (Gardner  and 
Woods,  1979),  which  can  relieve  the  defect  caused  by 
Yptlp-D124N but not by Yptlp-N121I (see below). 
Dominant Mutant YPT1 Proteins Are Defective in 
Guanine Nucleotide Binding 
The YPT1-D124N and YPTI-N121I mutations lie in a do- 
main of the protein that, by analogy to ras, is predicted to 
interact with the guanine nucleotide ring (Bourne et al., 
1991). This domain and the aspartate and asparagine resi- 
dues are highly conserved among all small GTP-binding 
proteins. We therefore examined the capacity of the wild 
type and mutant Yptl  proteins to bind  GDP and  GTP. 
Nucleotide binding experiments using Yptl proteins and 
3H-GDP were carried out, varying the molar ratio of GDP 
to protein from 1:1 to 50:1.  While nucleotide binding by 
wild  type Yptlp  was  clearly detectable  (at  least 80-fold 
above the background), no significant binding by mutant 
proteins was detected at even the highest GDP to protein 
ratio (data not shown). Since magnesium is necessary for 
strong guanine nucleotide binding, the rate of intrinsic nu- 
cleotide exchange can be accelerated dramatically by titra- 
tion of magnesium with EDTA (Hall and Self, 1986). We 
therefore determined nucleotide binding in the presence 
of EDTA. Wild type Yptlp bound GDP and GTP equally 
well under these conditions. In contrast, the Yptl-N121I 
and -D124N mutant proteins still failed to show significant 
binding to either GDP or GTP (Table I). Failure to bind 
nucleotides does not seem to affect the stability of these 
proteins for two reasons. Most importantly, these proteins 
inhibit the exchange factor for Yptlp  and protein trans- 
port in vitro; both effects can be relieved by XTP in the 
case of Ypt1-D124N (see below). In addition, the mutant 
proteins migrate appropriately according to their molecu- 
lar mass, like the wild type protein, using a Sepharose $300 
gel  filtration  column  followed  by  immunoblot  analysis 
(data not shown). 
Dominant Mutant Ypt  l  Proteins Completely 
Inhibit Stimulated Guanine Nucleotide Exchange 
for Wild Type Yptlp 
Genetic and  biochemical evidence suggests  that  certain 
dominant interfering EF-Tu and ras mutant proteins (e.g., 
EF-Tu-Q136E/K, Ras2p-G22A, H-ras-Nl16N), which are 
defective in  guanine  nucleotide binding,  sequester  their 
exchange  factors,  EF-Ts  and  Cdc25/Sdc25,  respectively 
(Hwang et al.,  1989; Powers et al., 1989; Lai et al.,  1993; 
Hwang et al., 1993). Ras proteins carrying these mutations 
have been shown to interfere with the ability of Cdc25 or 
Sdc25  to stimulate  the  exchange of guanine  nucleotides 
bound to wild type ras protein (Hwang et al., 1993; Haney 
and Broach, 1994). We have recently characterized a gua- 
Table L Yptl Dominant Mutant Proteins Are Defective in 
Guanine Nucleotide Binding 
Nucleotide Binding (pmol/pmol Yptlp) 
Yptl Protein  GDP  GTP 
wild type  0.215  0.223 
D 124N  <0.0001  <0.0002 
N121I  <0.0001  <0.0002 
Wild type and mutant Yptl proteins (2 ixM) were incubated with 3H-5',8'-GDP or 
32P-a-GTP (3.2 I~M) for 15 min at 30°C in the presence of sufficient EDTA to bring 
the free Mg  ÷ concentration to 0.1 lxM (Sunyer et al., 1984). Magnesium (5 mM) was 
then added to stabilize the nucleotide-protein complex. Samples were removed, fil- 
tered onto nitrocellulose, and quantitated by scintillation spectrophotometry. The data 
shown represent the averages of three independent determinations and agree to within 
11% of the mean. 
nine  nucleotide  exchange  activity  for  Yptlp.  This  ex- 
change factor is different from the other known exchange 
factor for rab proteins in yeast, Dss4p, since it is undimin- 
ished by deletion of the DSS4 gene (Jones, S., R. Litt, and 
N. Segev, manuscript in preparation). We wished to exam- 
ine whether the dominant interfering Yptl mutant proteins, 
Yptl-N121I and Ypt1-D124N, which are defective in gua- 
nine nucleotide binding, can block this exchange activity. 
Exchange  of guanine  nucleotide  bound  to  wild  type 
Yptlp was assayed by GDP release or GTP uptake. The 
P100 fraction (100,000 g pellet) of a crude yeast lysate was 
found to be enriched in a nucleotide exchange stimulating 
activity for Yptlp. The P100 fraction or an extract of it, 
TNS100, were used  in the following experiments as the 
source of this activity. Exchange assays were performed to 
follow stimulated release of 3H-GDP from preloaded wild 
type Yptlp, in the presence of varying amounts of wild 
type  or  mutant  Yptl  proteins.  Addition  of bacterially- 
expressed purified Yptl-N121I and Ypt1-D124N proteins 
inhibited the activity of the exchange factor in stimulating 
the release of 3H-GDP from Yptlp, in a concentration de- 
pendent manner (Fig. 2 a). Both mutant proteins also in- 
hibited stimulated uptake of 32p-GTP by wild type Yptlp 
(Fig. 2 b). The inhibitory characteristics of the two mutant 
proteins were  identical;  50%  of maximal  inhibition was 
achieved at 0.07 ~M inhibitory protein and complete inhi- 
bition at 0.3  ixM. In contrast to the mutant proteins, wild 
type  Yptlp  did  not  inhibit  stimulated  exchange,  even 
when added at a concentration of up to 3 ~M (Fig. 2 a). 
The inability of wild type Yptlp to inhibit the exchange re- 
action even at high concentrations suggests that the inter- 
action between the wild type Yptlp and the exchange fac- 
tor  is  transient.  In  contrast,  the  ability  of  the  mutant 
proteins to inhibit the exchange reaction at a very low con- 
centration suggests that the interaction between the mu- 
tant proteins and the exchange factor is more stable. We 
suggest that the  difference between the mutant  and the 
wild type Yptl proteins is due to the fact that while the 
mutant proteins are nucleotide-free, the wild type Yptlp is 
either  nucleotide  bound,  or  capable  of binding  nucleo- 
tides, which are present in excess in the assay mixture. The 
effect of the  mutant  proteins was  limited  to  stimulated 
guanine  nucleotide exchange; the  intrinsic  (uncatalized) 
exchange rate, which was about eightfold lower than the 
stimulated  exchange  rate,  was  not  affected  (data  not 
shown). This observation strongly suggests that the mutant 
protein does not complex with the wild type Yptlp in such 
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Figure  2.  Yptl-N121I  and 
-D124N  mutant  proteins 
completely  inhibit  stimu- 
lated guanine nucleotide ex- 
change on wild type Yptlp. 
(a)  Inhibition of stimulated 
GDP  release.  Guanine  nu- 
cleotide exchange was moni- 
tored by measuring the  re- 
lease  of  3H-GDP  from 
Yptlp. Reactions were sup- 
plemented  with  increasing 
amounts  of wild type Yptl 
(circles), Ypt1-N121I (trian- 
gles),  or  Yptl-D124N 
(squares)  proteins  ex- 
pressed in  bacteria. Assays 
were performed by preincu- 
bating competitor Yptl pro- 
teins with the P100  cellular 
fraction (1 ixg/ml) for 10-15 
rain on ice. Wild-type Yptl 
protein (0.1  IxM) preloaded 
with  3H-GDP  was  then 
added as a substrate and the reaction was incubated at 30°C for 
30 min. Samples were removed, filtered onto nitrocellulose, and 
quantitated  by  scintillation  spectrophotometry.  Values  pre- 
sented are the average of 2--4 experiments. Inhibition of stimu- 
lated exchange is expressed as inhibition of GDP release caused 
by the addition of Yptlp to the stimulated reaction elicited by 
the P100  fraction (42%  GDP release). Intrinsic exchange (6% 
GDP release), measured in a control reaction, in which BSA was 
added instead of P100, was subtracted. (b) Inhibition of stimu- 
lated GTP uptake. Guanine nucleotide uptake was monitored by 
measuring stimulated binding of a-s2P-GTP to Yptlp. Reactions 
were carried out in the absence (circles) or presence of 0.2 IxM 
Yptl-N121I (triangles), or Yptl-D124N (squares) proteins puri- 
fied from bacteria. Assays were performed as in Fig. 2 a, except 
that the source of exchange factor was the TNS100 extract of the 
P100 fraction and the amount of GTP bound to Yptlp was deter- 
mined by immunoprecipitation rather than filtration. Values pre- 
sented are the average of two experiments and are representa- 
tive of four experiments using two extracts. Intrinsic nucleotide 
exchange (assayed in the presence of ovalbumin) was measured 
at each time point and has been subtracted out to generate the 
values for stimulated exchange. Stimulated GTP uptake was in- 
hibited 65%  under these conditions. In 3H-GDP release assays 
carried out with TNS100,  under identical conditions, exchange 
was inhibited 60%. 
a way as to prevent release or binding of guanine nucleo- 
tides. Instead, it supports the model that inhibition of ex- 
change by the mutant proteins is due to interference with 
the interaction between wild type Yptlp and the exchange 
factor. 
Dominant Mutant Yptl Proteins Inhibit ER to Golgi 
Transport In Vitro at the Vesicle Consumption  Step 
Yptlp has been shown to be required for transport of pro- 
teins in a  cell-free system that reconstitutes ER to Golgi 
transport (Bacon et al., 1989; Baker et al., 1990). If stimu- 
lated nucleotide exchange is essential for Yptlp function 
in  protein  transport,  the  bacterially expressed dominant 
mutant proteins, which inhibit this process, should inhibit 
0 
0  0.5  1  1.5  2  2.5 
Yptl  protein  (gM) 
Figure  3.  Yptl-N121I  and 
Yptl-D124N  dominant  mu- 
tant  proteins  inhibit  ER  to 
Golgi transport in vitro. ER 
to  Golgi  transport  of 
35S-labeled  pro-a-factor was 
assayed in a cell-free reaction 
(Baker, et al., 1988). The in- 
dicated amounts  of purified 
recombinant  Yptl  proteins 
(wild  type  Yptl,  circles; 
Yptl-N121I, triangles; Yptl- 
D124N, squares) were added. 
Percent  transport  was  calculated as  percent  of ER  modified 
(core-glycosylated, Concanavalin A  [Con A] precipitable cpm) 
a-factor  that  acquired  Golgi-specific modification  (anti-a-l,6 
mannose precipitable cpm). Concentration of mutant protein re- 
quired for 50%  inhibition of transport varied among different 
preparations of fractions used in the reaction. Data presented are 
the average of three determinations using one set of fractions. 
ER to Golgi transport in vitro. Wild type and mutant Yptl 
proteins purified from E. coli were added to a reaction in 
which transport of a labeled protein is assayed by follow- 
ing  the  addition  of  compartment-specific  modifications 
(Baker et al., 1988,  1990).  Both mutant proteins were po- 
tent inhibitors of ER to Golgi transport (Fig. 3). 50% inhi- 
bition was achieved with 0.3  I~M Yptlp-N121t or Yptip- 
D124N;  maximal inhibition of ~75-85%  was achieved by 
adding  0.8  txM mutant  proteins.  In  contrast,  addition of 
comparable amounts of wild type Yptlp had no effect on 
transport. Thus, the mutant proteins are capable of acting 
as dominant inhibitors of protein transport in vitro as well 
as in vivo. Inhibition of the in vitro transport reaction was 
achieved at concentrations of mutant proteins that are in 
the same range as those required for inhibition of the ex- 
change  activity. Since  the  proteins were  purified from  a 
bacterial expression system, prenylation appears to be un- 
necessary for this inhibitory effect, as is also the case in 
vivo (see above). 
Yptlp is required for targeting and/or fusion of trans- 
port vesicles on their way to the Golgi complex from the 
ER. This was shown by the fact that inhibiting Yptlp func- 
tion, using either antibodies or fractions made from cells 
carrying a recessive yptl mutation, blocks the transport re- 
action at a step subsequent to vesicle budding from the ER 
(Rexach and  Schekman,  1991;  Segev,  1991).  If the domi- 
nant mutant protein causes the block in transport by inter- 
fering  with  wild  type  Yptlp  function,  it  is  expected  to 
block at the same step as the antibody or the recessive yptl 
mutation,  namely  after  vesicle  budding.  To  determine 
whether the dominant mutant proteins inhibited transport 
at this step,  the Yptlp-D124N-blocked in  vitro transport 
reaction was  assayed for accumulation  of transport vesi- 
cles.  This  assay  involved  determining  whether  an  ER- 
modified  marker  protein,  lacking  Golgi  modifications, 
accumulated in the supernatant after a medium-speed cen- 
trifugation  (Rexach  and  Schekman,  1991;  Segev,  1991). 
Even though protein transport to the Golgi complex was 
85%  blocked by the addition of Yptlp-D124N,  exit from 
the ER was as high as in control reactions (Fig. 4 a). The 
labeled marker protein that accumulated in the superna- 
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to Golgi transport  reaction  at  a step after  vesicle budding.  (a) 
Exit from the ER is not blocked by the Yptl-D124N mutant pro- 
tein. ER to Golgi in vitro transport of 3SS-labeled a-factor was as- 
sayed as described for Fig. 3. Either  no recombinant protein, or 
2.4 ixM wild type Yptl or Yptl-D124N  was added to the in vitro 
reaction. Samples were removed after incubation at 20°C for 60 
rain and fractionated by differential centrifugation. Samples were 
assayed for ER modified or Golgi modified a-factor in the total 
reaction  mixture and in the  medium speed supernatants  (MSS, 
1.2,000 g for 10 min) (Segev, 1991). The percent exit from the ER 
is calculated as the sum of the ER modified a-factor in the MSS 
plus Golgi modified u-factor in the total reaction, versus the total 
a-factor tanslocated into the ER (Con A precipitable cpm in the 
unfractionated  reaction)  (left). Percent transport  (right) is calcu- 
lated as in Fig. 3. Values presented are representative of three ex- 
periments.  (b) ER modified u-factor  accumulated in the Yptl- 
D124N-blocked  in  vitro  transport  reaction  is  enclosed  within 
membranes. The ER to Golgi in vitro transport reaction was car- 
ried out in the presence of Yptl-D124N protein as in a. Medium 
speed supernatant  containing intermediate  vesicles was treated 
with trypsin in the absence (lanes a-c) or presence (lanes d-C) of 
detergent  as described (Segev, 1991). After protease  treatment, 
samples were subjected to immunoprecipitation with antibody to 
ct-factor, followed by SDS PAGE and fluorography (cga f, core 
glycosylated a-factor; ppu f, pre-pro-a factor). Core glycosylated 
a-factor was accessible to protease  only when detergent  was in- 
cluded; protease  digestion was abolished by addition of trypsin 
inhibitor  (lanes c and f).  Pre-pro-a factor is the  untranslocated 
form of the marker protein and is accessible to protease even in 
the absence of detergent. 
tant was protease resistant  in the absence but not in the 
presence of detergent, demonstrating that it was enclosed 
within membranes (Fig.  4 b). Thus, Yptl-D124N protein 
blocks transport at  a  point subsequent  to vesicle forma- 
tion, but prior to vesicle consumption. This result is consis- 
tent with the interpretation that the Yptl-D124N mutant 
protein interferes with wild type Yptlp function. 
XTP, But Not GTP, Relieves the Inhibitory Effects of 
Ypt  l-D12 4N Protein 
The YPT1-D124N mutation is analogous to a well-charac- 
terized mutation of EF-Tu. This mutation, EF-Tu-D138N, 
has been shown to change the nucleotide specificity of the 
protein from GTP to XTP (Hwang and Miller, 1987). The 
mutant protein binds  and hydrolyzes XTP and performs 
its  normal function in  protein  translation  (Weijland  and 
Parmeggiani, 1993).  This change in nucleotide specificity 
has  also been  shown for the  analogous mutation  in  ras 
(McCormick et al.,  1987).  In addition, it has been shown 
that exchange factors for EF-Tu and ras have higher affin- 
ity for the nucleotide-free mutant protein than for the wild 
type protein containing either GTP or GDP (Hwang and 
Miller,  1985;  Lai et  al.,  1993;  Haney and Broach, 1994). 
Based on these two findings, we reasoned that if Yptlp- 
D124N, like EF-Tu-D138N, can bind XTP, the inhibition 
of stimulated guanine nucleotide exchange by Yptl-D124N 
might be relieved by allowing the mutant protein to bind 
this  nucleotide.  Thus,  binding of XTP  by Yptlp-D124N 
would reduce the  affinity of the  exchange factor for the 
mutant protein and would therefore reduce its effective- 
ness as an inhibitor in the exchange reaction. By this rea- 
soning,  the  reversal  of  inhibition  should  be  specific  to 
XTP; GTP would be ineffective because the mutant pro- 
tein cannot bind it. Moreover, if inhibition of the exchange 
activity for wild type Yptlp is the reason for the inhibitory 
effect of the mutant protein on protein transport in vitro, 
XTP should also alleviate the transport block. In contrast, 
inhibition of exchange and transport by the other interfer- 
ing mutant protein, Yptl-N121I, should not be relieved by 
the addition of XTP because that mutation is not expected 
to promote an interaction with XTP. 
To test these predictions, guanine nucleotide exchange 
assays were performed in the presence of Yptlp-D124N 
and Yptlp-N121I that had been preincubated with either 
GTP or XTP. Addition of XTP, but not GTP, relieved the 
inhibition of nucleotide exchange by Yptlp-D124N (Fig. 
5). Up to 80%  of the inhibition caused by Yptlp-D124N 
was reversed by addition of 200 t~M XTP, while reversal 
by GTP was  about  10-fold lower. The weak  effect seen 
with GTP may be due to some binding at these high nucle- 
otide concentrations, which were not achievable in the di- 
rect nucleotide binding assays shown in Table I. Relief of 
inhibition by XTP was specific to Yptlp-D124N; neither 
XTP nor GTP significantly affected the inhibition of ex- 
change by Yptlp-N121I (Fig. 5). 
To determine whether the inhibitory effects of Yptlp- 
D124N on nucleotide exchange and protein transport are 
related, we assessed the ability of XTP to reverse the inhi- 
bition  of  the  in  vitro  ER  to  Golgi  transport  reaction 
caused  by  Yptlp-D124N.  Increasing  concentrations  of 
XTP progressively reduced the inhibition of ER to Golgi 
transport caused by Yptlp-D124N. We used a concentra- 
tion of dominant mutant protein that elicited about 50% 
transport  inhibition.  Addition of 250  I~M XTP  restored 
transport  to  uninhibited  levels.  GTP was  approximately 
fivefold less effective than XTP. As expected, neither nu- 
cleotide  significantly alleviated  the  block caused  by the 
Yptlp-N121I  protein  (Fig.  6).  Similar  results  were  ob- 
tained in in vitro transport experiments using cytosol from 
yeast cells expressing the dominant mutant Yptl proteins. 
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Figure 5.  XTP alleviates the inhibition of stimulated guanine nu- 
cleotide exchange by Yptl-D124N protein. Yptl-D124N (squares) 
or Yptl-N121I (triangles) proteins (1.55 t~M) were preincubated 
with varying concentrations of nucleotide, XTP fit'lled symbols) 
or GTP (empty symbols), in the presence of 5 mM EDTA for 5 
min at 30°C, and then added to a final concentration of 0.09 txM 
to a GDP release assay as described for Fig. 2 a, except that incu- 
bation was carried for 60 min. At this time percent stimulated ex- 
change is 47.2 in the absence of inhibitory protein; and 17.7 in the 
presence of inhibitory protein. Results are presented as relief of 
stimulated exchange inhibition by nucleotides; nucleotide con- 
centration is the  concentration present in the  exchange  assay. 
Data shown are averages of two experiments and are representa- 
tive of at least three independent experiments. 
In these experiments both mutant cytosols inhibited trans- 
port,  but  only the  cytosol from  cells  expressing  Yptlp- 
D124N  could promote transport in the presence of XTP 
(data not shown). Thus, the dominant mutant proteins ex- 
pressed in yeast cells behave in the same way as the pro- 
teins expressed in bacteria. The ability of XTP  to relieve 
inhibition of both guanine nucleotide exchange and vesic- 
ular transport by Yptl-D124N protein indicates that  the 
nucleotide-free form of the mutant protein is the active in- 
hibitor. It further suggests that inhibition of ER to Golgi 
transport by the dominant mutant proteins is due to inhi- 
bition of the guanine-nucleotide exchange factor that acts 
on Yptlp. 
Discussion 
In this paper we provide strong support for an  essential 
role of an exchange factor that acts on a rab-type GTPase 
in  protein transport.  It  had  previously been  shown  that 
DSS4,  the only known yeast gene  encoding an exchange 
factor for arab protein, is not essential for viability. More- 
over,  its  function  does  not  seem  to  be  needed  for  cell 
growth or secretion (Moya et al., 1993). This observation 
was surprising because at least one of the rab proteins that 
Dss4 regulates, Sec4p, is essential for viability and secre- 
tion (Salminen and Novick, 1987), and it has left open the 
question of whether nucleotide exchange factors for rab- 
type  GTPases  play an  essential role.  Injection of Mss4p 
into the squid giant nerve terminal facilitates neurotrans- 
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Figure 6.  XTP alleviates the 
inhibition of in  vitro  trans- 
port caused by Yptl-D124N 
protein. Yptl-D124N inhibi- 
tion of ER to Golgi in vitro 
transport is relieved by XTP 
(filled  symbols)  but  not  by 
GTP (empty symbols). Yptl- 
D124N  (squares)  or  Ypt1- 
N121I (triangles) mutant pro- 
teins,  or  wild-type  (circles) 
(2.5  IxM)  were  incubated 
with  various  concentrations 
of nucleotide for  10 rain on 
ice prior to addition to the in 
vitro transport mixture as described in Fig. 3. Final concentration 
of Yptlp in the assay mixture was 0.8 ixM. Data shown are aver- 
ages of two experiments and are representative of at least three 
independent experiments using different sets of fractions. There 
are several possible reasons for the lower concentration of XTP 
needed for the  relief of exchange inhibition (Fig. 5)  versus in 
vitro transport inhibition (Fig. 6): First, the concentration of mu- 
tant  proteins used  in  the  exchange  inhibition experiment was 
about 10-fold lower than that used in the in vitro transport exper- 
iment (0.09 and 0.8 IxM, respectively). Second, the preloading of 
the Yptl proteins with XTP  for the  exchange experiment was 
done in the presence of EDTA at 30°C, for more efficient load- 
ing. EDTA was not used in the transport experiments, since it in- 
hibits this reaction, and the preloading was done on ice. Third, in 
the GDP release assay the concentration of nucleotides, which 
might  protect  the  added XTP  from  degradation, was  75-fold 
higher than that included in the in vitro transport reaction (1.5 
mM and 20 ixM, respectively). 
mitter release, suggesting a  role for this exchange  factor 
for rab proteins in vesicular transport (Burton et al., 1994). 
Our results strongly suggest that the nucleotide exchange 
factor for  Yptlp is  essential for its function  in  vesicular 
transport. Thus, purified dominant mutant Yptl proteins, 
N121I and D124N, inhibit both stimulated nucleotide ex- 
change for wild type Yptlp and in vitro ER to Golgi pro- 
tein transport. Inhibition of both stimulated exchange and 
the transport reactions exhibit similar characteristics: simi- 
lar amounts of the mutant Yptl proteins are required, and 
inhibition by Yptlp-D124N can be relieved by the addi- 
tion of XTP.  We have evidence to suggest that the domi- 
nant mutant proteins do not block other known accessory 
proteins that regulate Yptlp function, such as a  GTPase- 
activating protein  (GAP)  or  a  GDI.  Our  recent  results 
demonstrate that the dominant mutant proteins do not in- 
hibit a  GAP activity that acts on Yptlp (Jones, S., and N. 
Segev, unpublished data). GDI is probably not the target 
for these mutant proteins since it has been shown to inter- 
act  exclusively with the prenylated form  of rab  proteins 
(Araki  et  al.,  1990;  Regazzi  et  al.,  1992;  Soldati  et  al., 
1993), and we found that unprenylated Yptl mutant pro- 
teins act in a  dominant inhibitory fashion in vitro and in 
vivo.  While it  is  still a  formal  possibility that  an  unde- 
scribed Yptl-interacting protein that is essential for pro- 
tein transport is also a target for the dominant mutant pro- 
teins,  evidence  from  two  other  GTPases  supports  the 
interpretation that the exchange factor is the only target 
for these nucleotide-free dominant mutant proteins. The 
dominant effect of mutations in yeast RAS2 and bacterial 
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nucleotide binding  and  that  sequester  their cognate ex- 
change factors, can be suppressed in vivo by over-expres- 
sion of the gene for the relevant exchange factor. Thus, 
RAS2-G22A  can  be  suppressed  by  over-expression  of 
Cdc25p,  the  exchange  factor  for  Ras2p,  and  EF-Tu- 
K136E/Q can be suppressed by over-expression of EF-Ts, 
the exchange factor for EF-Tu (Powers et al., 1989; Hwang 
et al., 1989, respectively). The conservation between Yptl, 
ras and EF-Tu with regard to the behavior of these mu- 
tants (defects in nucleotide binding, inhibition of the nu- 
cleotide  exchange  factor  and  the  change  in  nucleotide 
specificity of the  D124N  mutant  protein  from  GTP  to 
XTP) strongly suggests that other aspects of their function 
will also be conserved. In addition, except for DSS4,  ex- 
change factors for GTPases that are essential for viability 
are themselves essential: e.g., CDC25 (see above) (Broek 
et al.,  1987;  Robinson et al.,  1987),  and SEC12,  the ex- 
change factor for SAR1, which encodes a GTPase that is 
involved in the vesicle budding step of protein transport 
(Nakano et al., 1988; Barlowe and Schekman, 1993). DSS4 
might be exceptional either because there is a second nu- 
cleotide exchange factor for Sec4p, or because Sec4p func- 
tion  is  less  dependent  on  such  a  factor,  as  it  has  been 
shown  to possess  a  high rate  of intrinsic  nucleotide ex- 
change (Moya et al., 1993). The conclusion about the es- 
sential role of the exchange factor that acts on Yptlp must 
now be supported by genetic and biochemical analyses af- 
ter the gene has been identified. 
The mechanism by which mutations in the NKXD con- 
sensus domain of rab proteins exert their dominance is not 
known. Our results suggest that the Yptl-N121I and Yptl- 
D124N mutant proteins exert their dominant effects by in- 
terfering with the wild type Yptlp function, and that this 
interference is  achieved by the  sequestration  of the  ex- 
change  factor for Yptlp  by the  nucleotide-free mutant 
protein. This model has been suggested for dominant in- 
terfering ras and EF-Tu mutations in the NKXD domain 
(see above). Our data support the generalization of this 
mode of dominance to rab-type GTPases. The suggestion 
that the  dominant mutant Yptl  proteins are nucleotide- 
free is supported by two pieces of evidence. First, we could 
not detect binding of GDP or GTP by these proteins. Sec- 
ond, the inhibition caused by the Yptlp-D124N could be 
relieved by the addition of XTP, the nucleotide that it is 
predicted to bind. The further suggestion that the domi- 
nant effect of these proteins on protein transport is  ex- 
erted by interference with the interaction of the wild type 
Yptlp and its exchange factor is supported by two facts. 
First, inhibition of both the stimulated exchange and the 
transport reactions show similar characteristics (see above). 
Second, the  block of transport  caused  by the  dominant 
protein is identical to the block caused by loss of function 
of Yptlp (Rexach and Schekman, 1991; Segev, 1991), in a 
step that lies between vesicle budding and vesicle fusion 
with the target membrane. The sequestration of the ex- 
change factor by a dominant interfering mutant rab pro- 
tein, makes such mutations valuable tools for the genetic 
or biochemical isolation of exchange factors for rab-type 
GTPases. 
YPT1-D124N is  a  novel dominant mutation of YPT1. 
This mutation is analogous to the EF-Tu-D138N mutation, 
which has been shown to alter the nucleotide specificity of 
that protein from GTP to XTP (Hwang and Miller, 1987). 
Weijland and Parmeggiani (1993) demonstrated that bind- 
ing of XTP to the mutant protein allowed it to perform its 
normal function. Likewise, the analogous mutation in H-ras, 
Dl19N, was demonstrated to have little or no effect on its 
interaction with exchange factors, GAP, and Raf (Zhong 
et al.,  1995).  The data presented above strongly suggest 
that a similar change in nucleotide specificity is caused by 
the YPT1-D124N mutation. Thus, both of the inhibitory 
effects caused by this mutant protein can be alleviated by 
the addition of XTP. Since this similarity exists between 
proteins as distant in function and primary structure (out- 
side the GTP-binding consensus domains) as EF-Tu, ras, 
adenylosuccinate synthetase and Yptl (Hwang and Miller, 
1987; McCormick et al., 1987; Kang et al., 1994; and this 
study, respectively) we predict that the analogous muta- 
tion will also cause the change in specificity from GTP to 
XTP in other rab proteins. Such mutations can be used for 
functional  analysis  of  yeast  and  mammalian  tab-type 
GTPases in a conditional manner, since the dominant in- 
hibitory effect is reversed by adding  XTP. Most impor- 
tantly, such mutations can be used to follow an individual 
GTPase in crude extracts, since the mutant protein will be 
the only "GTPase" in the cell extract that can utilize XTP 
(Weijland and Parmeggiani, 1993). 
There are several open questions regarding the function 
of  exchange  factors  for  tab  proteins.  One  question  is 
whether exchange factors have specific rab targets. This 
question is especially important since dominant mutations 
analogous to the YPT1-N121I have been used for the elu- 
cidation of specific steps  at which different rab proteins 
function in vivo and in vitro (Gorvel et al., 1991; Bucci et 
al.,  1992; Tisdale et al.,  1992; Wilson et al.,  1994).  Since 
these mutations probably exert their inhibition by seques- 
tering exchange factors, such experiments will not be con- 
clusive until the specificity of the relevant exchange factor 
has been determined. Yeast Dss4p and mammalian Mss4 
can stimulate release of GDP in vitro from more than one 
rab, i.e., not  only from Sec4, but also to a  lesser extent 
from Yptl and Rab3A  (Burton et al., 1993; Moya et al., 
1993). Mss4 was shown to interact with a subset of the rab 
GTPase family that is involved in the exocytic pathway, in- 
cluding  the  Yptlp  mammalian  functional  homologue, 
Rabl (Burton et al., 1994). It is not clear whether this lack 
of specificity also exists in vivo. On the other hand, the ex- 
change activity that we have identified appears to act pref- 
erentially on Yptlp in vitro; the new factor, present in a 
crude cellular fraction, does not stimulate nucleotide ex- 
change for Sec4p, which is the closest known family mem- 
ber of Yptlp in yeast cells (Jones, S., R. J. Litt, and N. Se- 
gev, manuscript in preparation). In addition, the Yptlp- 
N121I  mutant,  which  inhibits  the  exchange  activity for 
Yptlp, does not seem to perturb Sec4p function in vivo. 
This  mutation  elicits  blocks  only in  the  early secretory 
steps that are dependent on Yptlp function (Jedd, G., C. J. 
Richardson, R. J. Litt, and N. Segev, manuscript in prepa- 
ration). However, we cannot rule out the possibility that 
the exchange factor that we have identified can stimulate 
nucleotide exchange by other rab GTPases that function 
in the yeast exocytic pathway. Another question concerns 
the mechanism of action of the exchange factors for rab 
Jones et al. Requirement of  Exchange Factor  for Yptl GTPase  1059 proteins. They might be needed exclusively for regulation 
of the cycling of tab proteins from the GDP- to the GTP- 
bound form. In that case, the incomplete block of both the 
in vivo and in vitro transport elicited by the dominant mu- 
tant Yptl proteins might be explained by the unstimulated 
exchange of nucleotide bound to the wild type Yptlp. Al- 
ternatively, exchange  factors for tab proteins could have 
additional functions such as recruitment of tab proteins to 
membranes  (Dirac-Svejstrup  et  al.,  1994;  Soldati  et  al., 
1994;  Ullrich  et  al.,  1994),  promoting  interaction  of rab 
proteins  with  other  proteins  during  complex  formation 
(Lian et al., 1994; S0garrd et al., 1994), or serve as targets 
for regulation by other enzymatic systems. The latter func- 
tion was  suggested  for the GTPase  cascade  in yeast bud 
formation, which involves regulation of an exchange factor 
for one GTPase by another GTPase (Chant, 1994). Isolat- 
ing the genes that encode exchange factors for the differ- 
ent rab proteins and determining the subcellular localiza- 
tion of their  protein products  should help  resolve  these 
issues. 
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